Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Blood|April 14, 2005
Identification and characterization of epitopes of the receptor for hyaluronic acid-mediated motility (RHAMM/CD168) recognized by CD8+ T cells of HLA-A2-positive patients with acute myeloid leukemiaJochen Greiner, Li Li, Mark Ringhoffer, et al.
International Journal of Oncology|March 10, 2006
Immunotherapy for patients with acute myeloid leukemia using autologous dendritic cells generated from leukemic blastsLi Li, Krzysztof Giannopoulos, Peter Reinhardt, et al.
International Journal of Cancer|November 1, 2015
Immune responses to WT1 in patients with AML or MDS after chemotherapy and allogeneic stem cell transplantationRosaely Casalegno-Garduño, Anita Schmitt, Alf Spitschak, et al.
Blood Advances|September 8, 2021
Fatal late-onset CAR T-cell-mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphomaSusanne Jung, Jochen Greiner, Stephanie von Harsdorf, et al.
Experimental Hematology|July 16, 2008
Dasatinib exerts an immunosuppressive effect on CD8+ T cells specific for viral and leukemia antigensFei Fei, Yingzhe Yu, Anita Schmitt, et al.
Cancer Immunology, Immunotherapy : CII|September 30, 2006
Imatinib impairs CD8+ T lymphocytes specifically directed against the leukemia-associated antigen RHAMM/CD168 in vitroJinfei Chen, Anita Schmitt, Baoan Chen, et al.
Oncology Research and Treatment|June 17, 2020
A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer SocietyLothar Bergmann, Viktor Grünwald, Luise Maute, et al.
British Journal of Haematology|January 16, 2007
Reduced-intensity conditioning followed by T-cell depleted allogeneic stem cell transplantation for patients with chronic myeloid leukaemia and minimal residual disease at the time of transplant: high risk of molecular relapseMark Ringhoffer, Stephanie von Harsdorf, Michael Schmitt, et al.
Blood|August 26, 2006
Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approachesJochen Greiner, Michael Schmitt, Li Li, et al.
Journal of Cellular and Molecular Medicine|July 20, 2007
mRNA-mediated gene delivery into human progenitor cells promotes highly efficient protein expressionJuliane M Wiehe, Peter Ponsaerts, Markus T Rojewski, et al.
Pageof 8